Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Melanoma Research
|
April 1, 1993
Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial
D B Thomson, M Adena, G R McLeod, et al.
British Journal of Cancer
|
September 30, 2010
Pooled analysis of recent studies on magnetic fields and childhood leukaemia
L Kheifets, A Ahlbom, C M Crespi, et al.
Cancer Treatment Reports
|
December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patients
R M Lowenthal, C N Chesterman, J D Griffiths, et al.
Bone Marrow Transplantation
|
November 25, 1998
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience
R M Lowenthal, C Fabères, G Marit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2011
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
N C Tebbutt, F Murphy, D Zannino, et al.
Blood
|
March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
J F Bishop, J P Matthews, G A Young, et al.
Leukemia & Lymphoma
|
September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)
R M Lowenthal, K F Bradstock, J P Matthews, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
I D Davis, A Long, S Yip, et al.
British Journal of Haematology
|
June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia
J P Matthews, J F Bishop, G A Young, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Melanoma Research
|
April 1, 1993
Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial
D B Thomson, M Adena, G R McLeod, et al.
British Journal of Cancer
|
September 30, 2010
Pooled analysis of recent studies on magnetic fields and childhood leukaemia
L Kheifets, A Ahlbom, C M Crespi, et al.
Cancer Treatment Reports
|
December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patients
R M Lowenthal, C N Chesterman, J D Griffiths, et al.
Bone Marrow Transplantation
|
November 25, 1998
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience
R M Lowenthal, C Fabères, G Marit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2011
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
N C Tebbutt, F Murphy, D Zannino, et al.
Blood
|
March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
J F Bishop, J P Matthews, G A Young, et al.
Leukemia & Lymphoma
|
September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)
R M Lowenthal, K F Bradstock, J P Matthews, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
I D Davis, A Long, S Yip, et al.
British Journal of Haematology
|
June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia
J P Matthews, J F Bishop, G A Young, et al.
Page
of 10